Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Mitoxantrone × Head & Neck × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Thyroid Cancer, Papillary 1

Interventions

Cisplatin 28 toripalimab 12 Radiotherapy 12 pembrolizumab 11 Gemcitabine 11 Capecitabine 10 Radiotherapy, Intensity-Modulated 9 Docetaxel 9 tislelizumab 8 Surgical Procedures, Operative 8 Carboplatin 8 Paclitaxel 6 Fluorouracil 6 Drug Therapy 6 Taxes 5 Cetuximab 5 sintilimab 4 Magnetic Resonance Spectroscopy 4 130-nm albumin-bound paclitaxel 4 trametinib 3 anlotinib 3 Watchful Waiting 3 Thyroxine 3 Standard of Care 3 Specimen Handling 3 Immune Checkpoint Inhibitors 3 Cyclophosphamide 3 Blood Specimen Collection 3 Biopsy 3 trilaciclib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07354698 2026-01-21

MHI

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phase 4 Not yet recruiting

EndocrineHead & Neck

Thyroid Cancer, Papillary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡